110 related articles for article (PubMed ID: 27048321)
1. NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells.
Tateno T; Nakano-Tateno T; Ezzat S; Asa SL
Endocr Relat Cancer; 2016 May; 23(5):445-56. PubMed ID: 27048321
[TBL] [Abstract][Full Text] [Related]
2. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract][Full Text] [Related]
3. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
4. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.
Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA
J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390
[TBL] [Abstract][Full Text] [Related]
7. TGFβ signaling reinforces pericyte properties of the non-endocrine mouse pituitary cell line TtT/GF.
Tsukada T; Yoshida S; Kito K; Fujiwara K; Yako H; Horiguchi K; Isowa Y; Yashiro T; Kato T; Kato Y
Cell Tissue Res; 2018 Feb; 371(2):339-350. PubMed ID: 29274061
[TBL] [Abstract][Full Text] [Related]
8. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas.
Asa SL; Puy LA; Lew AM; Sundmark VC; Elsholtz HP
J Clin Endocrinol Metab; 1993 Nov; 77(5):1275-80. PubMed ID: 8077321
[TBL] [Abstract][Full Text] [Related]
9. Research resource: T-antigen transformation of pituitary cells captures three novel cell lines in the Pit-1 lineage.
Sizova D; Ho Y; Cooke NE; Liebhaber SA
Mol Endocrinol; 2010 Nov; 24(11):2232-40. PubMed ID: 20829390
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.
Yadavilli S; Scafidi J; Becher OJ; Saratsis AM; Hiner RL; Kambhampati M; Mariarita S; MacDonald TJ; Codispoti KE; Magge SN; Jaiswal JK; Packer RJ; Nazarian J
Oncotarget; 2015 May; 6(14):12141-55. PubMed ID: 25987129
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and biomarker profile of pituitary adenohypophysial tumors.
Mete O; Cintosun A; Pressman I; Asa SL
Mod Pathol; 2018 Jun; 31(6):900-909. PubMed ID: 29434339
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.
Hu N; Gutsmann A; Herbert DC; Bradley A; Lee WH; Lee EY
Oncogene; 1994 Apr; 9(4):1021-7. PubMed ID: 8134105
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.
Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W
Endocrinology; 1992 Nov; 131(5):2083-9. PubMed ID: 1425411
[TBL] [Abstract][Full Text] [Related]
14. Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
Hsu SC; Nadesan P; Puviindran V; Stallcup WB; Kirsch DG; Alman BA
J Biol Chem; 2018 Feb; 293(7):2466-2475. PubMed ID: 29196603
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis.
Parisi T; Bronson RT; Lees JA
Oncogene; 2009 Jan; 28(4):500-8. PubMed ID: 18997819
[TBL] [Abstract][Full Text] [Related]
16. Changes in the proliferative capacity of NG2 cell subpopulations during postnatal development of the mouse hippocampus.
Moshrefi-Ravasdjani B; Dublin P; Seifert G; Jennissen K; Steinhäuser C; Kafitz KW; Rose CR
Brain Struct Funct; 2017 Mar; 222(2):831-847. PubMed ID: 27306788
[TBL] [Abstract][Full Text] [Related]
17. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
[TBL] [Abstract][Full Text] [Related]
18. A role for the NG2 proteoglycan in glioma progression.
Stallcup WB; Huang FJ
Cell Adh Migr; 2008; 2(3):192-201. PubMed ID: 19262111
[TBL] [Abstract][Full Text] [Related]
19. Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis.
Yin Z; Williams-Simons L; Parlow AF; Asa S; Kirschner LS
Mol Endocrinol; 2008 Feb; 22(2):380-7. PubMed ID: 17975024
[TBL] [Abstract][Full Text] [Related]
20. Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.
Lama G; Mangiola A; Proietti G; Colabianchi A; Angelucci C; D' Alessio A; De Bonis P; Geloso MC; Lauriola L; Binda E; Biamonte F; Giuffrida MG; Vescovi A; Sica G
J Neuropathol Exp Neurol; 2016 Feb; 75(2):134-47. PubMed ID: 26792897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
